Open Payments Expansion Act

This bill would require drug and medical device manufacturers, and certain group purchasing organizations, to report to the federal Department of Health and Human Services the payments or other transfers of value they make to patient advocacy organizations. Reports would be due starting March 31, 2027, and then on the 90th day of each year after that. Each report would include the name of the organization and the amount of the payment. Payments made indirectly through a third party at the manufacturer's direction would also have to be reported. A patient advocacy organization is defined as a tax-exempt 501(c)(3) charity that provides patient education, advocacy, or support, focuses on a diagnosed medical condition, or helps people affected by medical conditions and their families.

Full text and official record on Congress.gov

Sponsors

• Chuck Grassley Republican sponsor
• 1 cosponsors